Conference

https://www.linkedin.com/posts/avenna-ltd_glycans-are-crucial-in-covid-19-infection-activity-6785481637766414336-4xrj

WuXi HealthCare forum presentation

WuXi HealthCare forum presentation In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease. Click here to see

WuXi HealthCare forum presentation Read More »